Arcadia Biosciences Inc
$ 0.70
-2.73%
07 Aug - close price
- Market Cap 1,518,300 USD
- Current Price $ 0.70
- High / Low $ 0.72 / 0.69
- Stock P/E N/A
- Book Value 1.40
- EPS -5.77
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.33 %
- ROE -1.58 %
- 52 Week High 5.72
- 52 Week Low 0.59
About
Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.
Analyst Target Price
$12.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-26 | 2025-11-07 | 2025-08-14 | 2025-05-08 | 2025-03-20 | 2024-11-12 | 2024-08-13 | 2024-05-09 | 2024-03-28 | 2023-11-09 | 2023-08-10 |
| Reported EPS | -2.1053 | -0.9759 | 0.62 | -3.26 | 1.9 | -2.99 | -0.87 | 0.78 | -1.78 | -2.52 | -1.89 | 0.61 |
| Estimated EPS | None | -0.09 | -0.54 | -0.79 | -0.98 | -0.89 | -0.77 | 1.55 | -2.21 | -2.58 | -2.93 | -4.92 |
| Surprise | 0 | -0.8859 | 1.16 | -2.47 | 2.88 | -2.1 | -0.1 | -0.77 | 0.43 | 0.06 | 1.04 | 5.53 |
| Surprise Percentage | None% | -984.3333% | 214.8148% | -312.6582% | 293.8776% | -235.9551% | -12.987% | -49.6774% | 19.457% | 2.3256% | 35.4949% | 112.3984% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: RKDA
2026-08-01 04:40:53
Arcadia Biosciences Inc (RKDA) currently holds a financial score of 6.21, ranking 76th out of 94 companies in the Food & Tobacco industry. The company's financial status is considered robust, but its operating efficiency is low. Its recent quarterly revenue was $1.10M, marking an 8.33% year-over-year decrease, while net profit fell by 268.72% year-over-year.
2026-08-01 04:40:53
Verdeca, a joint venture of Arcadia Biosciences and Bioceres Crop Solutions, has received USDA approval for its HB4 drought-tolerant soybeans, allowing for commercialization in the U.S. This follows FDA approval in 2017. The HB4 trait is now approved in over 80% of the global soybean market, with regulatory submissions ongoing in several other countries.
2026-07-30 16:39:17
This article provides a comprehensive stock analysis of Arcadia Biosciences Inc (RKDA) from TradingKey. It highlights that RKDA has relatively healthy fundamentals and significant growth potential, although its valuation is considered fair within the Food & Tobacco industry. The stock is currently trading sideways, making it suitable for range-bound swing trading, despite a weak market performance recently.
2026-07-30 03:11:29
This article provides details on the institutional confidence score for Arcadia Biosciences Inc (RKDA), which stands at 3.00, unchanged from its previous score. It lists key institutional shareholders and their recent activity, including shares held and percentage change. The data highlights institutional investor holdings and shifts in their positions for RKDA.
2026-07-28 04:04:46
This article provides a detailed cash flow statement for Arcadia Biosciences Inc (RKDA), covering quarterly and annual data for operating, investing, and financing activities. It presents key financial figures, year-over-year changes, and includes an FAQ section explaining different types of cash flow and RKDA's performance in these areas. The data highlights RKDA's operating cash flow, which was -4.74M in fiscal 2025, and its financing cash flow of 6.00K in the latest quarter.
2026-07-28 03:43:00
This article provides a risk assessment for Arcadia Biosciences Inc (RKDA), noting its current risk score of 1.33, ranking 81 out of 93 in the Food & Tobacco industry. The company's beta of 0.51 suggests it is less volatile than the S&P 500. The report details various metrics related to volatility, drawdown, and liquidity, highlighting the stock's historical performance in these areas.
